IRF2BP2 and squamous cell carcinoma: This is particularly relevant in cases where RUNX2 rearrangements or IRF2BP2::RUNX2 fusion have been identified, as seen in studies of primary squamous cell carcinoma of the parotid, where certain cases were later reclassified as keratocystoma or squamous cell carcinoma ex-keratocystoma [31].